The Daily Buyout
$10.9BStrategic acquisitionHealthcare & Life SciencesCompleted

AbbVie Completes $10.9B Acquisition of Apogee Therapeutics

AbbVie closed its acquisition of Apogee Therapeutics, paying shareholders $135.11 per share in cash for a total equity value of about $10.9 billion.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

More Healthcare & Life Sciences deals